Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

Samankaltaisia teoksia

• Guidelines for the proper use of etanercept in Japan
  Tekijä: Miyasaka, Nobuyuki, et al.
  Julkaistu: (2006)
• Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
  Tekijä: Yamanaka, Hisashi, et al.
  Julkaistu: (2016)
• Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
  Tekijä: Nishimoto, Norihiro, et al.
  Julkaistu: (2008)
• Study of active controlled monotherapy used for rheumatoid arthritis, an IL‐6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader‐blinded randomised controlled trial of tocilizumab
  Tekijä: Nishimoto, Norihiro, et al.
  Julkaistu: (2007)
• Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
  Tekijä: Hashimoto, Jun, et al.
  Julkaistu: (2010)